Registry for patients with chronic total coronary occlusions
Chronic Total Occlusion Registry
This study is collecting information from patients with blocked heart arteries to see how well different treatments work and to improve care for these procedures.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Leuven) |
| Trial ID | NCT02352818 on ClinicalTrials.gov |
What this trial studies
This registry aims to collect comprehensive data on patients undergoing procedures for chronic total coronary occlusions (CTOs). It will gather information on patient demographics, cardiac risk factors, procedural details, and outcomes. The study will evaluate the safety and effectiveness of various CTO-specific devices and techniques, as well as track complications and clinical outcomes at one year post-procedure. The goal is to improve understanding and management of CTO procedures.
Who should consider this trial
Good fit: Ideal candidates include patients undergoing elective percutaneous revascularization for chronic total occlusions.
Not a fit: Patients who do not consent to having their personal data included in the registry will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could enhance the safety and effectiveness of treatments for patients with chronic total coronary occlusions.
How similar studies have performed: Other studies have shown success in similar registries, indicating that this approach can yield valuable insights into patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All consecutive patients undergoing an elective attempt at percutaneous revascularization of a chronic total occlusion are eligible for inclusion in the CTO registry. A chronic total occlusion is defined as an occluded coronary artery with TIMI 0 flow that has been occluded for 3 months or more. By definition all patients will have been judged to be acceptable candidates for an attempt at revascularization before consenting to be part of the CTO registry. Exclusion Criteria: * There are no specific exclusion criteria. If the patient does not wish to consent to having his personal data kept in a registry the patient will not be included in the CTO registry.
Where this trial is running
Leuven
- Department of Cardiovascular Disease, University Hospitals Leuven — Leuven, Belgium (Recruiting)
Study contacts
- Study coordinator: Johan Bennett, MD
- Email: johan.bennett@uzleuven.be
- Phone: 003216341916
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.